These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24573216)

  • 41. Influence of pH, nutrient availability, and growth rate on amine production by Bacteroides fragilis and Clostridium perfringens.
    Allison C; Macfarlane GT
    Appl Environ Microbiol; 1989 Nov; 55(11):2894-8. PubMed ID: 2560361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brachyspira (Serpulina) pilosicoli of human origin interfere with the growth of Clostridium perfringens alpha-toxin producer.
    Calderaro A; Dettori G; Ragni P; Guégan R; Arcangeletti MC; Medici MC; Chezzi C
    New Microbiol; 2002 Apr; 25(2):139-47. PubMed ID: 12019719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maternal vaccination against subclinical necrotic enteritis in broilers.
    Lovland A; Kaldhusdal M; Redhead K; Skjerve E; Lillehaug A
    Avian Pathol; 2004 Feb; 33(1):83-92. PubMed ID: 14681072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stable L-forms of Clostridium perfringens: growth, toxin production, and pathogenicity.
    Mahony DE
    Infect Immun; 1977 Jan; 15(1):19-25. PubMed ID: 188763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterologous production and secretion of Clostridium perfringens beta-toxoid in closely related Gram-positive hosts.
    Nijland R; Lindner C; van Hartskamp M; Hamoen LW; Kuipers OP
    J Biotechnol; 2007 Jan; 127(3):361-72. PubMed ID: 16959352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunization with an alphatoxin variant 121A/91-R212H protects mice against Clostridium perfringens alphatoxin.
    Schoepe H; Neubauer A; Schlapp T; Wieler LH; Baljer G
    Anaerobe; 2006 Feb; 12(1):44-8. PubMed ID: 16701610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toxin production by Clostridium perfringens isolated from broiler chickens and capercaillies (Tetrao urogallus) with and without necrotizing enteritis.
    Hofshagen M; Stenwig H
    Avian Dis; 1992; 36(4):837-43. PubMed ID: 1485870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Removal of proteases from Clostridium perfringens fermented broth by aqueous two-phase systems (PEG/citrate).
    Porto TS; Pessôa-Filho PA; Neto BB; Filho JL; Converti A; Porto AL; Pessoa A
    J Ind Microbiol Biotechnol; 2007 Aug; 34(8):547-52. PubMed ID: 17566805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Total combining power: Technique for the evaluation of the quality control process of clostridiosis vaccines.
    Brandi IV; Santos EM; Carvalho BM; Durães CA; Farias PK; Sari RS; Cangussu AS; Pessoa A
    J Microbiol Methods; 2016 Nov; 130():164-168. PubMed ID: 27569385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model.
    Shreya D; Uppalapati SR; Kingston JJ; Sripathy MH; Batra HV
    Mol Immunol; 2015 May; 65(1):51-7. PubMed ID: 25645504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficient conversion of lactic acid to butanol with pH-stat continuous lactic acid and glucose feeding method by Clostridium saccharoperbutylacetonicum.
    Oshiro M; Hanada K; Tashiro Y; Sonomoto K
    Appl Microbiol Biotechnol; 2010 Jul; 87(3):1177-85. PubMed ID: 20502892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variable protection after vaccination of broiler chickens against necrotic enteritis using supernatants of different Clostridium perfringens strains.
    Lanckriet A; Timbermont L; Eeckhaut V; Haesebrouck F; Ducatelle R; Van Immerseel F
    Vaccine; 2010 Aug; 28(36):5920-3. PubMed ID: 20600504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The titration of clostridial toxoids and antisera in cell culture.
    Knight PA; Burnett C; Whitaker AM; Queminet J
    Dev Biol Stand; 1986; 64():129-36. PubMed ID: 2878845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Neonatal diarrhoea in pigs: alpha- and beta2-toxin produced by Clostridium perfringens].
    Hendriksen SW; van Leengoed LA; Roest HI; van Nes A
    Tijdschr Diergeneeskd; 2006 Dec; 131(24):910-3. PubMed ID: 17278609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a flow cytometric bead immunoassay and its assessment as a possible aid to potency evaluation of enterotoxaemia vaccines.
    Buys A; Macdonald R; Crafford J; Theron J
    J S Afr Vet Assoc; 2014 Mar; 85(1):977. PubMed ID: 24832497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Weakly beta-haemolytic human intestinal spirochaetes antagonize the haemolytic activity of Clostridium perfringens alpha-toxin producer.
    Calderaro A; Dettori G; Grillo R; Cattani P; Ragni P; Guégan R; Fadda G; Chezzi C
    New Microbiol; 2001 Apr; 24(2):125-36. PubMed ID: 11346295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pathogenicity of various toxinogenic types of Clostridium perfringens administered by mouth to axenic and holoxenic mice].
    Hudault S; Bridonneau C; Raibaud P
    Ann Microbiol (Paris); 1983; 134B(2):277-83. PubMed ID: 6316828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro tests for the measurement of clostridial toxins, toxoids and antisera. II. Titration of Clostridium perfringens toxins and antitoxins in cell culture.
    Knight PA; Queminet J; Blanchard JH; Tilleray JH
    Biologicals; 1990 Oct; 18(4):263-70. PubMed ID: 2285500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An international survey of clostridial sera and vaccines.
    Davidson I
    Dev Biol Stand; 1976; 32():3-14. PubMed ID: 187508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Formation of toxins by Clostridium perfringens types C and D].
    Urguev KR
    Veterinariia; 1970 Jun; 6():98-9. PubMed ID: 4320342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.